Skip to content
Review

RNA modifications and metabolism in cancer: mechanisms, cross-talk and therapeutic implications.

Sep 2026 · Seminars in Cancer Biology · pp. 102622 · 0 citations · 387 references
Medicine

TL;DR

This review synthesizes current knowledge on how RNA modifications coordinate glucose, lipid, glutamine and nucleotide metabolism, with emphasis on cross-talk and functional integration among different marks to discuss tumor-type-specific wiring of these networks.

Abstract

RNA modifications, particularly in the realm of epitranscriptomics, have emerged as crucial regulatory factors in cancer progression, influencing cancer cell behavior by reprogramming metabolic pathways. These modifications, such as N⁶-methyladenosine (m⁶A), 5-methylcytosine (m⁵C), N¹-methyladenosine (m¹A), N⁷-methylguanosine (m⁷G), N⁴-acetylcytidine (ac⁴C) and pseudouridine (Ψ), modulate mRNA stability, splicing, translation efficiency, and non-coding RNA function, thereby fine-tuning the expression of metabolic enzymes and transporters. Importantly, these marks converge on shared metabolic enzymes, engage common effector proteins, and exhibit synergistic, antagonistic or hierarchical relationships that collectively shape the metabolic landscape of tumors. This review synthesizes current knowledge on how RNA modifications coordinate glucose, lipid, glutamine and nucleotide metabolism, with emphasis on cross-talk and functional integration among different marks. We further discuss tumor-type-specific wiring of these networks, the challenges of multi-modification detection, and the therapeutic potential of targeting the epitranscriptomic-metabolic axis in precision oncology.

View source

Similar papers

Review Open access Oct 2026

Dynamic regulation of H3K9 modifications in cancer: pathogenesis and targeted therapies

Post-translational modifications (PTMs) of histone H3 at lysine 9 (H3K9) contribute to chromatin homeostasis and transcriptional regulation and have been implicated in cancer progression. However, how distinct H3K9 modification states differ in function, compete for the same lysine residue, and dynamically respond to c...

Yuan-Yuan Xu, Qi-Hui Wu, Yu-Xiu Zhang et al. · 0 citations
Review Aug 2026

RNA modifications as determinants of cancer cell death: from epitranscriptomic mechanisms to therapeutic targeting

It is argued that while epitranscriptomics represents a compelling regulatory axis in cancer cell death, advancing the field will require integrative, high-resolution, and functionally precise approaches to move beyond correlative frameworks toward mechanistic and clinically actionable insights.

A. Mukherjee, Ankit Kumar Bharti, D. Mathew et al. · 0 citations
Review Open access Sep 2026

The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy

Histone methylation regulates chromatin structure and gene expression, whereas tumor metabolism provides bioenergetic and biosynthetic inputs. These processes are bidirectionally linked: S-adenosylmethionine supplies methyl groups for histone methyltransferases, α-ketoglutarate(α-KG) supports JmjC-domain demethylases,...

Jia-Yao Dou, Rui-Cheng Xue, Wei Gao et al. · 0 citations
Review Open access Aug 2026

Histone modifications: mechanisms, metabolic regulation, and therapeutic targeting in cancer

This review comprehensively summarizes the multifaceted roles of major histone modifications, including acetylation, methylation, ubiquitination, phosphorylation, and emerging metabolism-linked acylations, in governing critical DNA-templated processes such as replication, transcription, and the DNA damage response.

Ling-Li Wang, Shi-Ying Li, Xiao-Yan Hu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.